Molina Healthcare exits S&P 500—what's next for investors?

Molina Healthcare will leave the S&P 500 index on 23 March 2026. The company, a major provider of Medicaid and Medicare services in the U.S., is being replaced alongside three other firms. Four new entries—Vertiv Holdings, Lumentum Holdings, Coherent Corp., and EchoStar Corporation—will take their place.

The decision follows S&P Dow Jones Indices' regular review of market capitalisation, profitability, and sector balance. Molina's removal could impact its stock price in the short term, though analysts see both risks and potential opportunities for investors.

Molina Healthcare specialises in managed care for low-income Americans through government-funded programs. Its business model depends heavily on Medicaid and Medicare, making it sensitive to political shifts in U.S. healthcare regulation. Despite this vulnerability, the company has posted steady financial results in recent quarters, though rising medical costs have squeezed profit margins.

The S&P 500 exclusion may create short-term pressure on Molina's share price. Historically, stocks removed from the index have dropped by 5 to 10 percent. Some traders interpret the move as a negative signal, while others view it as a chance to buy an undervalued stock compared to rivals like UnitedHealth or Humana.

For European investors, particularly in the DACH region, Molina still offers exposure to the U.S. healthcare market. The company benefits from stable government funding and an ageing population. Even after leaving the S&P 500, its liquidity is expected to remain strong, as it may still appear in other indices such as the S&P MidCap 400 or Russell 2000.

The removal from the S&P 500 takes effect on 23 March 2026. Molina Healthcare's future performance will depend on its ability to manage medical costs and navigate regulatory changes. Investors will now weigh whether the stock's lower valuation outweighs the risks tied to its government-dependent business model.